Molecular imaging with engineered physiology

In vivo imaging techniques are powerful tools for evaluating biological systems. Relating image signals to precise molecular phenomena can be challenging, however, due to limitations of the existing optical, magnetic and radioactive imaging probe mechanisms. Here we demonstrate a concept for molecular imaging which bypasses the need for conventional imaging agents by perturbing the endogenous multimodal contrast provided by the vasculature. Variants of the calcitonin gene-related peptide artificially activate vasodilation pathways in rat brain and induce contrast changes that are readily measured by optical and magnetic resonance imaging. CGRP-based agents induce effects at nanomolar concentrations in deep tissue and can be engineered into switchable analyte-dependent forms and genetically encoded reporters suitable for molecular imaging or cell tracking. Such artificially engineered physiological changes, therefore, provide a highly versatile means for sensitive analysis of molecular events in living organisms. ; National Institute of Mental Health (U.S.) (R01-MH103160) ; National Institute of Mental Health (U.S.) (R01-NS076462) ; BRAIN Initiative (award R24-MH109081) ; Massachusetts Institute of Technology. Simons Center for the Social Brain ; Boehringer Ingelheim Fonds (predoctoral fellowships) ; McGovern Institute for Brain Research at MIT